These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. [Basic data on antibiotic therapy]. Cah Med; 1971 Dec; 12(17):1424-50. PubMed ID: 5149495 [No Abstract] [Full Text] [Related]
43. Approach to the use of antimicrobial combinations. Saag MS Ala J Med Sci; 1985 Jan; 22(1):72-5. PubMed ID: 3883831 [No Abstract] [Full Text] [Related]
44. Antibiotic therapy for severe bacterial infections: correlation between the inhibitory quotient and outcome. Spanu T; Santangelo R; Andreotti F; Cascio GL; Velardi G; Fadda G Int J Antimicrob Agents; 2004 Feb; 23(2):120-8. PubMed ID: 15013036 [TBL] [Abstract][Full Text] [Related]
45. Antibacterial activity of benzydamine and antibiotic-benzydamine combinations against multifold resistant clinical isolates. Fanaki NH; El-Nakeeb MA Arzneimittelforschung; 1996 Mar; 46(3):320-3. PubMed ID: 8901158 [TBL] [Abstract][Full Text] [Related]
46. [Changes in antibiotic sensitivity of urinary bacteria]. Schmid W Med Welt; 1980 Mar; 31(10):379-81. PubMed ID: 7392912 [No Abstract] [Full Text] [Related]
47. Early diagnosis and therapy of bacterial corneal ulcers. Jones DB Int Ophthalmol Clin; 1973; 13(4):1-29. PubMed ID: 4784000 [No Abstract] [Full Text] [Related]
48. [Use of the method of double gradient plates for determination of antibiotic combinations synergistic against Staphylococci]. Finn GR; Teterina LM Antibiotiki; 1972 Feb; 17(2):141-6. PubMed ID: 5023458 [No Abstract] [Full Text] [Related]
50. Development of antibiotic resistance: a vet's tale. Wray C J Med Microbiol; 1997 Jan; 46(1):26-33. PubMed ID: 9003742 [No Abstract] [Full Text] [Related]
51. [Treatment with antibacterial chemotherapy]. Schauer J; Tauchnitz C Z Gesamte Inn Med; 1992 Sep; 47(9):386-90. PubMed ID: 1441664 [TBL] [Abstract][Full Text] [Related]
52. Synergistic activity of piperacillin: YTR-830H combinations in vitro and in vivo. Kuck NA; Petersen PJ; Weiss WJ; Jacobus NV; Testa RT; Tally FP J Chemother; 1989 Jul; 1(4 Suppl):105-6. PubMed ID: 16312325 [No Abstract] [Full Text] [Related]
54. [General rules of management of an antibiotic treatment]. Cah Med; 1971 Dec; 12(17):1451-79. PubMed ID: 5170002 [No Abstract] [Full Text] [Related]
55. [Anti-bacterial effect of ofloxacin--in vitro and in vivo results]. Altay G; Tulunay C Mikrobiyol Bul; 1985 Oct; 19(4):183-9. PubMed ID: 3868736 [TBL] [Abstract][Full Text] [Related]
56. [Immunomodulating effects of antibiotics alone and in conjunction with immunosuppressive drugs]. Gillissen G Z Arztl Fortbild (Jena); 1992 Mar; 86(6):263-7. PubMed ID: 1590005 [No Abstract] [Full Text] [Related]
57. Anaerobic infections--the most important antimicrobial drugs and their clinical profile. Solberg CO Scand J Gastroenterol Suppl; 1983; 85():14-22. PubMed ID: 6353550 [No Abstract] [Full Text] [Related]
58. [Reflections on antibiotic therapy]. Mashimo K Nihon Rinsho; 1984 Mar; 42(3):696-8. PubMed ID: 6471459 [No Abstract] [Full Text] [Related]
59. When "S" does not mean success: the importance of choice of antibiotic and dose on clinical and economic outcomes of severe infection. Gillespie EL; Kuti JL; Nicolau DP Conn Med; 2005 Apr; 69(4):203-10. PubMed ID: 15926635 [TBL] [Abstract][Full Text] [Related]